AngioScore

AngioScore

Signal active

Organization

Contact Information

Overview

AngioScore Inc. develops, manufactures and markets the AngioSculpt Scoring Balloon Catheter for both the coronary and peripheral interventional markets.

Designed specifically to address the limitations of conventional angioplasty balloon catheters, AngioSculpt combines a semi-compliant balloon with an innovative nitinol scoring element.

About

Industries

Biotechnology, Health Care, Medical

Founded

2003

Employees

51-100

Headquarters locations

United States, North America

Social

N/A

Profile Resume

AngioScore headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $4.2B in funding across 48 round(s). With a team of 51-100 employees, AngioScore is actively contributing to advancements in Biotechnology. Their latest funding round, Series E - AngioScore, raised $30.0M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace James Andrews

James Andrews

SVP & CFO

imagePlace Thomas R. Trotter

Thomas R. Trotter

President, CEO

Funding Rounds

Funding rounds

4

Investors

6

Lead Investors

0

Total Funding Amount

$87.0M

Details

3

AngioScore has raised a total of $87.0M in funding over 3 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2006Late Stage Venture30.0M
2004Early Stage Venture15.0M
2007Late Stage Venture30.0M

Investors

AngioScore is funded by 19 investors.

Investor NameLead InvestorFunding RoundPartners
Innomed Ventures-FUNDING ROUND - Innomed Ventures15.0M
Jim Dreyfous-FUNDING ROUND - Jim Dreyfous15.0M
AngioScore-FUNDING ROUND - AngioScore15.0M
Pelion Venture Partners-FUNDING ROUND - Pelion Venture Partners15.0M

Recent Activity

There is no recent news or activity for this profile.